Bridging Policy to Practice: Navigating the 340B Program

Educational

Moderator Amir Emamifar, who's career spans more than 30 years a clinical pharmacist, leads a panel discussion on the topic "Bridging Policy to Practice: Navigating the 340B Program's Landscape and Embracing Opportunities featuring the following panelist:

Patti Hawkins, PharmD - Interim Administrator for Oncology Services and serves on the clinical faculty at the Union University School of Pharmacy

Christopher Hatwig, MS, RPh, FASHP - President at Apexus

Lisa Scholz, PharmD, MBA, FACHE - Vice President of 340B Enterprise Strategy at AmerisourceBergen

Panelist, Lisa Scholz, Overview of Presentation on "Bridging Policy to Practice: Navigating the 340B Program's Landscape And Embracing Opportunities"

LEARNING OUTCOMES

Identify the key legislative, judicial and administrative challenges of the 340B Program
Discuss health-system leading practices resulting from recent 340B policy updates impacting access, reimbursement, and eligibility
Discuss the solutions and technology capabilities utilized by covered entities to monitor 340B program performance

Latest Videos

View all Videos

Executive Insights

Executive Interview with Hinnah Farooqi

Feb 25, 2025

Hinnah Farooqi serves as the Director of Pharmacy at New York Presbyterian in Queens, a diverse hospital with 500 beds. She discusses the hospital's efforts to improve efficiency and patient safety by using more automation, like RFID technology called Intelligard. Hinnah also emphasizes teamwork with the central sterile team and the hospital's focus on developing leaders and improving management skills through partnerships and internal programs.

Executive Interview with Valerie Hoffman

Feb 25, 2025

Valerie Hoffman is the Associate Marketing Director at Long Grove Pharmaceuticals. Valerie prioritizes drug safety and aims to enhance it through clear, distinctive labeling. She also emphasizes open communication in leadership and works to build strong customer relationships.

Executive Insights

Executive Interview with Mark Saxon

Feb 10, 2025

Mark Saxon, the CEO of Safecor Health, discusses the company's strategic plans for 2025, emphasizing their commitment to unit dose drug repackaging and error-free medication delivery. Mark highlights the importance of cultural change and core values such as care, commitment, and excellence in leadership. He expresses excitement about tackling healthcare challenges, cherishes family traditions, and is looking forward to a successful 2025.